Researchers performed a meta-analysis to determine the prevalence of antidepressant discontinuation symptoms.
AC-0676 by Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes